Business
US biotech Novavax could make COVID vaccine onshore in Australia – Sydney Morning Herald
The company behind Australia’s third major coronavirus vaccine candidate says it would be happy to set up shop in Australia, just like its competitor Moderna.
American biotechnology company Novavax has outlined plans to make doses of its coronavirus vaccine in Australia after revealing it is searching for a manufacturing partner to produce its protein-based jab onshore.
The federal government has ordered 51 million doses of Novavaxs product, which is still awaiting regulatory clearances in the US and Australia. In an interview with The Sydney Morning Herald and The Age, Novavaxs chief commercial officer John Trizzino said the company has had early conversations…
-
Noosa News21 hours agoFervor Wines label started during pandemic keeps father and son close
-
Business23 hours agoThese ASX 200 shares could rise 15% to 20%
-
Business22 hours agoEvery ASX 200 sector closed in the red last week. Here’s why
-
Business24 hours agoBuy NDQ ETF and these popular funds with $5,000